机器人辅助支气管镜与CT引导经胸活检诊断肺结节的比较
该多中心回顾性研究对比了机器人辅助支气管镜(RAB)与CT引导经胸活检(CTTB)诊断疑似肺癌肺结节的效果。共纳入225例患者,RAB组113例,CTTB组112例。RAB总体诊断率87.6%,CTTB为88.4%;恶性病变敏感性RAB 82.1%、CTTB 88.5%,特异性均100%。CTTB并发症发生率显著更高(17% vs. 4.4%,p=0.002)。结论认为RAB在可及情况下可达到与CTTB相似的诊断准确性,且并发症更少或相当。
要点
- RAB与CTTB诊断肺结节的总体诊断率相似(87.6% vs. 88.4%)。
- CTTB并发症发生率显著高于RAB(17% vs. 4.4%,p=0.002)。
- 需同时进行纵隔分期时,可考虑优先选择RAB。
核心结论
- RAB在可及情况下诊断肺结节的准确性可与CTTB相当,且并发症更少或相似。
- 当临床需要同时完成纵隔和肺门分期时,RAB应作为结节活检的考虑方式。
研究设计与样本
- 多中心回顾性研究,连续纳入2019年1月至2021年3月在美国Mayo Clinic Florida和Mayo Clinic Rochester接受RAB或CTTB评估肺结节的患者。
- 共纳入225例患者,RAB组113例,CTTB组112例;比较临床人口学信息、结节特征、结局和并发症。
主要发现
- 总体诊断率:RAB为87.6%,CTTB为88.4%。
- 恶性病变敏感性:RAB为82.1%,CTTB为88.5%;两者特异性均为100%。
- 并发症发生率:CTTB为17%,RAB为4.4%,差异有统计学意义(p=0.002)。
关键数值与推荐
- RAB总体诊断率87.6%,CTTB总体诊断率88.4%。
- RAB恶性病变敏感性82.1%、特异性100%;CTTB敏感性88.5%、特异性100%。
- CTTB并发症发生率17%,RAB为4.4%(p=0.002)。
临床怎么用
- 对于疑似肺癌的肺结节,RAB可作为CTTB的替代活检方式,尤其适用于需同期进行纵隔分期的患者。
- 选择活检方式时应权衡诊断准确性与并发症风险,CTTB并发症发生率更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Currently, computed tomography-guided transthoracic biopsy (CTTB) is the most accurate diagnostic approach for pulmonary nodules suspected of malignancy. Traditional bronchoscopy has shown suboptimal diagnostic sensitivity, but the emergence of robotic-assisted bronchoscopy (RAB) has the potential to improve diagnostic accuracy, maximize diagnostic yield and complete mediastinal and hilar staging in a single procedure. We aim to assess the efficacy and diagnostic performance of RAB compared to CTTB for diagnosing pulmonary nodules suspected of lung cancer. METHODS: A multicenter retrospective review of consecutive patients who underwent RAB and CTTB for evaluating pulmonary nodules from January 2019 to March 2021 at Mayo Clinic Florida and Mayo Clinic Rochester, United States. Clinical and demographic information, nodule characteristics, outcomes and complications were compared between RAB and CTTB. RESULTS: A total of 225 patients were included: 113 in the RAB group and 112 in the CTTB group. Overall diagnostic yield was 87.6% for RAB and 88.4% for CTTB. For malignant disease, RAB had a sensitivity of 82.1% and a specificity of 100%, CTTB had a sensitivity of 88.5% and a specificity of 100%. Complication rate was significantly higher for CTTB compared to RAB (17% vs. 4.4%; p = 0.002). CONCLUSION: RAB, when available, can be as accurate as CTTB for sampling pulmonary nodules with similar or reduced complications and should be considered as a means for nodule biopsy, particularly when mediastinal staging is also clinically warranted.
引用
- Yu Lee-Mateus A, Reisenauer J, Garcia-Saucedo JC, et al. Robotic-assisted bronchoscopy versus CT-guided transthoracic biopsy for diagnosis of pulmonary nodules. Respirology. 2022. PMID: 36104312. doi:10.1111/resp.14368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。